Retatrutide 60 mg Injectable
Advanced Triple-Receptor Weight Loss & Metabolic Optimization Therapy
Retatrutide is an innovative next-generation peptide designed to support significant weight loss, appetite control, metabolic health, and overall body composition improvement. Unlike traditional GLP-1 medications, Retatrutide activates three key metabolic pathways—GLP-1, GIP, and Glucagon receptors—to promote enhanced fat loss while helping preserve lean muscle mass.
By targeting multiple mechanisms involved in hunger regulation, energy expenditure, and glucose metabolism, Retatrutide may help individuals achieve greater weight loss results than previous generations of weight management therapies.
Potential Benefits:
• Significant weight loss support
• Reduced appetite and food cravings
• Improved blood sugar regulation
• Enhanced metabolic efficiency
• Increased fat burning and energy expenditure
• Support for long-term weight management
• May help preserve lean muscle mass during weight loss
Product Details
• 60 mg Retatrutide per vial
• Subcutaneous injection
• Physician-guided treatment protocols
• Convenient once-weekly dosing
Who May Benefit?
Individuals seeking advanced medical weight loss support, improved metabolic health, appetite control, and comprehensive body composition optimization.
Ultimate Prime Health
Research Driven. Results Focused.
Optimize Health. Maximize Performance. Live At Your Prime.